title: Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke.
abstract: Mice transgenic for antisense Notch and normal mice treated with inhibitors of the Notch-activating enzyme gamma-secretase showed reduced damage to brain cells and improved functional outcome in a model of focal ischemic stroke. Notch endangers neurons by modulating pathways that increase their vulnerability to apoptosis, and by activating microglial cells and stimulating the infiltration of proinflammatory leukocytes. These findings suggest that Notch signaling may be a therapeutic target for treatment of stroke and related neurodegenerative conditions.
authors: Laboratory of Neurosciences, National Institute on Aging Intramural Research Program, 5600 Nathan Shock Drive, Baltimore, Maryland 21224, USA.
authors: Thiruma V
authors: TV
authors: Arumugam
authors: Sic L
authors: SL
authors: Chan
authors: Dong-Gyu
authors: DG
authors: Jo
authors: Gokhan
authors: G
authors: Yilmaz
authors: Sung-Chun
authors: SC
authors: Tang
authors: Aiwu
authors: A
authors: Cheng
authors: Marc
authors: M
authors: Gleichmann
authors: Eitan
authors: E
authors: Okun
authors: Vishwa D
authors: VD
authors: Dixit
authors: Srinivasulu
authors: S
authors: Chigurupati
authors: Mohamed R
authors: MR
authors: Mughal
authors: Xin
authors: X
authors: Ouyang
authors: Lucio
authors: L
authors: Miele
authors: Tim
authors: T
authors: Magnus
authors: Suresh
authors: S
authors: Poosala
authors: D Neil
authors: DN
authors: Granger
authors: Mark P
authors: MP
authors: Mattson